Clinical Trial Update: Trifluridine/Tipiracil and Talazoparib for the Treatment of Patients With Locally Advanced or Metastatic Colorectal or Gastroesophageal Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating the combination of Lonsurf (trifluridine/tipiracil) and Talzenna (talazoparib) for locally advanced or metastatic colorectal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Gastroesophageal Junction Adenocarcinoma

Drugs mentioned

• Lonsurf (trifluridine/tipiracil)
• Talzenna (talazoparib)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Advanced Malignant Solid Neoplasm, Clinical Stage III Gastroesophageal Junction Adenocarcinoma | Phase 1 | Status: RECRUITING